yeah well that's what I'm unsure about.this company is...

yeah well that's what I'm unsure about.

this company is fast losing good faith in terms of its commitment to timeframes. investors were supposed to start seeing things moving 6 months ago. management then declared the DFS would be delayed to first quarter CY22. money sitting in GRV is becoming the poster child of lazy money. and we all know how much investors love that.

you're right in that the promised product might be enough to offset the negative sentiment of yet another delay. and I hope that's the case. but this new product could also be interpreted as just another focus shift in a long line of costly focus shifts. they were adamant there were good cost reasons to skip PFS and go straight to DFS. now they're undermining themselves by reversing directions like this. why can't these guys settle on a goal?

IMO the quarterly will have to be extremely definitive in order to allay market concerns. but if the current track record is anything to go by - they're more interested in "getting things done" (apparently) than keeping the market informed. so based on evidence, and not my hopes and dreams, I'm not super optimistic there'll be a great amount of specific detail - that won't be undone in 6 months time anyway.

but what do I know? I think the market reaction to whatever comes out, whichever way it goes, will be a great indicator of market sentiment.

here's hoping for a good one.

all my uninformed opinion only. certainly not advice. dyor.